Detalles de la búsqueda
1.
Comparison of immune infiltrates in melanoma and pancreatic cancer highlights VISTA as a potential target in pancreatic cancer.
Proc Natl Acad Sci U S A
; 116(5): 1692-1697, 2019 01 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-30635425
2.
Endocannabinoid system acts as a regulator of immune homeostasis in the gut.
Proc Natl Acad Sci U S A
; 114(19): 5005-5010, 2017 05 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-28439004
3.
The distribution of T-cell subsets and the expression of immune checkpoint receptors and ligands in patients with newly diagnosed and relapsed acute myeloid leukemia.
Cancer
; 125(9): 1470-1481, 2019 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30500073
4.
Dendritic cells sequester antigenic epitopes for prolonged periods in the absence of antigen-encoding genetic information.
Proc Natl Acad Sci U S A
; 109(43): 17543-8, 2012 Oct 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-23045695
5.
CD13 regulates dendritic cell cross-presentation and T cell responses by inhibiting receptor-mediated antigen uptake.
J Immunol
; 188(11): 5489-99, 2012 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-22544935
6.
Durvalumab and tremelimumab before surgery in patients with hormone receptor positive, HER2-negative stage II-III breast cancer.
Oncotarget
; 15: 238-247, 2024 Mar 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-38502947
7.
Molecular pathways and cellular subsets associated with adverse clinical outcomes in overlapping immune-related myocarditis and myositis.
Cancer Immunol Res
; 2024 May 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-38768394
8.
Myeloid-specific KDM6B inhibition sensitizes glioblastoma to PD1 blockade.
Nat Cancer
; 4(10): 1455-1473, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37653141
9.
A phase 2 study of nivolumab combined with ibrutinib in patients with diffuse large B-cell Richter transformation of CLL.
Blood Adv
; 7(10): 1958-1966, 2023 05 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-36287248
10.
Immune and pathologic responses in patients with localized prostate cancer who received daratumumab (anti-CD38) or edicotinib (CSF-1R inhibitor).
J Immunother Cancer
; 11(3)2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36948506
11.
Inflammation induced by tumor-associated nerves promotes resistance to anti-PD-1 therapy in cancer patients and is targetable by interleukin-6 blockade.
Res Sq
; 2023 Jul 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-37503252
12.
Neoadjuvant chemotherapy plus nivolumab with or without ipilimumab in operable non-small cell lung cancer: the phase 2 platform NEOSTAR trial.
Nat Med
; 29(3): 593-604, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36928818
13.
Investigative needle core biopsies for multi-omics in Glioblastoma.
medRxiv
; 2023 Dec 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-38234840
14.
A composite T cell biomarker in pre-treatment blood samples correlates with detection of immune-related adverse events.
Cancer Cell
; 40(3): 249-251, 2022 03 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-35290784
15.
A phase 1-2 trial of sitravatinib and nivolumab in clear cell renal cell carcinoma following progression on antiangiogenic therapy.
Sci Transl Med
; 14(641): eabm6420, 2022 04 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-35442707
16.
Perioperative nivolumab monotherapy versus nivolumab plus ipilimumab in resectable hepatocellular carcinoma: a randomised, open-label, phase 2 trial.
Lancet Gastroenterol Hepatol
; 7(3): 208-218, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-35065057
17.
Combined CTLA-4 and PD-L1 blockade in patients with chemotherapy-naïve metastatic castration-resistant prostate cancer is associated with increased myeloid and neutrophil immune subsets in the bone microenvironment.
J Immunother Cancer
; 9(10)2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34663638
18.
Pilot study of Tremelimumab with and without cryoablation in patients with metastatic renal cell carcinoma.
Nat Commun
; 12(1): 6375, 2021 11 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-34737281
19.
Single cell T cell landscape and T cell receptor repertoire profiling of AML in context of PD-1 blockade therapy.
Nat Commun
; 12(1): 6071, 2021 10 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-34663807
20.
Nodal immune flare mimics nodal disease progression following neoadjuvant immune checkpoint inhibitors in non-small cell lung cancer.
Nat Commun
; 12(1): 5045, 2021 08 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-34413300